with

Menarini Group Presents Elacestrant (ORSERDU) Phase 2 Combination Data in Patients with ER+, HER2- Metastatic Breast Cancer (mBC) at the 2025 San Antonio Breast Cancer Symposium

In addition, the expansive elacestrant clinical development program updates reinforce its potential as a backbone endocrine therapy in combination settings, as…

1 hour ago

Investment of Approx. USD 460,000 for the Development of a Prototype Mpox Detection Test with NIPRO, TBA, Japan Institute for Health Security and others

TOKYO, Dec. 8, 2025 /PRNewswire/ -- The Global Health Innovative Technology (GHIT) Fund announced today an investment of approximately JPY 70 million…

1 hour ago

ADFW Opens with Spotlight on Abu Dhabi’s Global Ambition and Major Humanitarian Pledge

ABU DHABI, UAE, Dec. 8, 2025 /PRNewswire/ -- Abu Dhabi Finance Week (ADFW) 2025 opened today with some of the…

2 hours ago

With Child Deaths Projected to Rise for the First Time in a Century, Gates Foundation and Mohamed Bin Zayed Foundation for Humanity Urge Action as World Faces Critical Turning Point

 At Goalkeepers Abu Dhabi, global leaders outline a path to improve and save the lives of millions of children through…

2 hours ago

Altair HyperWorks 2026 Delivers Design and Simulation at Scale with AI

Latest release enables faster, more confident design decisions at scale with accelerated simulation, AI-powered, real-time feedback, and GPU-accelerated reduced order modelingTROY,…

9 hours ago

Eastman Auto & Power Accelerates Its Global Energy Portfolio with New Telecom Battery & Hybrid Inverter Range

Showcases next-generation power solutions at infraXchange Singapore 2025NEW DELHI, Dec. 8, 2025 /PRNewswire/ -- Eastman Auto & Power Ltd., one…

9 hours ago

Allison Worldwide Expands Global Leadership with New Europe CEO

Former Hotwire UK CEO and Edelman MD Jeremy Lucas to turbocharge Allison's European capabilitiesLONDON, Dec. 8, 2025 /PRNewswire/ -- Allison…

13 hours ago

Lyell Immunopharma Presents New Clinical Data from Ongoing Trial of Ronde-Cel Showing High Rates of Durable Complete Responses in Patients with Large B-cell Lymphoma at the 67th ASH Annual Meeting and Exposition

93% overall response and 76% complete response rates with median progression-free survival of 18 months in patients with large B-cell…

1 day ago

BioNTech and OncoC4 Announce Clinically Meaningful Overall Survival Benefit for Selective Treg Modulator Gotistobart in Patients with Previously Treated Squamous Non-Small Cell Lung Cancer

Selective Treg modulator gotistobart (BNT316/ONC-392) showed a reduction in the risk of death by more than half compared to standard…

2 days ago

Abu Dhabi signs agreements and explores opportunities to strengthen partnerships with India and Singapore

ABU DHABI, Dec. 6, 2025 /PRNewswire/ -- The Abu Dhabi economic delegation, led by the Abu Dhabi Department of Economic…

2 days ago